— Know what they know.
Not Investment Advice

GLUC OTC

Glucose Health, Inc.
1W: +12.1% 1M: -0.1% 3M: -0.1% YTD: +109.0% 1Y: +798.8% 3Y: +83.7% 5Y: -84.3%
$0.45
+0.10 (+26.87%)
 
OTC · Consumer Defensive · Packaged Foods · Tech Score Buy · Power 58 · $7.7M mcap · 15M float · 0.119% daily turnover · Short 73% of daily vol

Balance Sheet Trends

Total Assets
$322K -19.2% ▼
5Y CAGR: +8.0%
Total Liabilities
$387K +174.6% ▲
5Y CAGR: +0.3%
Shareholders Equity
-$65K -125.2% ▼
Cash & Investments
$27K -87.0% ▼
5Y CAGR: -10.6%
Total Debt
$234K +0.0% ▲
5Y CAGR: -6.9%
Net Debt
$208K +202.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$69K$752K$267K$204K$27K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$69K$752K$267K$204K$27K
Net Receivables$18K$29K$24K$19K$16K
Inventory$254K$268K$304K$172K$249K
Other Current Assets$0$0$0$0$0
Total Current Assets$341K$1M$595K$395K$302K
Property, Plant & Equip.$0$0$0$0$17K
Goodwill & Intangibles$3K$3K$3K$3K$3K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$3K$3K$3K$3K$21K
Total Assets$345K$1M$598K$399K$322K
— Liabilities —
Accounts Payable$0$10K$21K$83K$16K
Short-Term Debt$112K$0$0$0$234K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$164K$0$0$58K$137K
Total Current Liabilities$304K$10K$21K$141K$387K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$304K$10K$21K$141K$387K
— Equity —
Common Stock$12K$14K$17K$17K$17K
Retained Earnings-$7M-$8M-$8M-$9M-$9M
Accumulated OCI-$75K-$178K-$17K-$75K$0
Total Stockholders Equity$41K$1M$577K$258K-$65K
Total Liabilities & Equity$345K$1M$598K$399K$322K
— Key Metrics —
Total Debt$112K$0$0$0$234K
Net Debt$43K-$752K-$267K-$204K$208K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms